Finance

Beta
Lists
SMNR:OTCMKTS
Semnur Pharmaceuticals Inc
$4.89
+57.74%
(+1.79) 1D
Jun 10, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SMNR...
Open
$4.89
High
$4.89
Low
$4.89
Mkt. cap
1.13B
Avg. vol.
142.00
Volume
502.00
52-wk high
$23.00
52-wk low
$3.00
EPS
-$0.47
Beta
-115.44
Shares outstanding
230.21M
No. of employees
10
Open
$4.89
High
$4.89
Low
$4.89
Mkt. cap
1.13B
Avg. vol.
142.00
Volume
502.00
52-wk high
$23.00
52-wk low
$3.00
EPS
-$0.47
Beta
-115.44
Shares outstanding
230.21M
No. of employees
10
News stories
From sources across the web
About Semnur Pharmaceuticals Inc
CEO-
Employees10
Founded2013
HeadquartersPalo Alto, California, United States
SectorPharmaceutical industry
Websitesemnurpharma.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
502.00K
1.14M
714.00K
1.27M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
497.00K
151.45M
5.44M
3.31M
Operating expense
999.00K
152.59M
6.16M
4.58M
Total operating expenses
999.00K
152.59M
6.16M
4.58M
Operating income
-999.00K
-152.59M
-6.16M
-4.58M
Other non operating income
-
-
-
-
EBT including unusual items
-999.00K
-152.59M
-6.16M
-4.58M
EBT excluding unusual items
-999.00K
-152.59M
-6.16M
-4.58M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-999.00K
-152.59M
-6.16M
-4.58M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer